Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) — Cash Flow Reinvestment Rate
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (301096) has a Cash Flow Reinvestment Rate of 16.10x as of December 2023, reinvesting CN¥1.46 Billion (capex CN¥688.60 Million plus investments CN¥-767.42 Million) from operating cash flow of CN¥90.45 Million. Explore 301096 capex to operating cash flow ratio to see what proportion of operating cash flow is directed to capital expenditures.
Reinvestment Rate
Total Reinvested
Operating Cash Flow
Capital Expenditures
Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. Cash Flow Reinvestment Rate (2019–2023)
Historical reinvestment intensity for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. across 5 annual periods. Also explore Hangzhou Bio-Sincerity Pharma-Tech Co.Lt balance sheet assets for the complete picture of this company's asset base.
Annual Cash Flow Reinvestment Rate for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd. (2019–2023)
Year-by-year capital reinvestment analysis for Hangzhou Bio-Sincerity Pharma-Tech Co.Ltd.. For live market cap and broader valuation context, see market value of Hangzhou Bio-Sincerity Pharma-Tech Co.Lt.
| Year | Reinvestment Rate | Total Reinvested (CNY) | Operating CF | Capex | YoY Change |
|---|---|---|---|---|---|
| 2023 | 16.10x | CN¥1.46 Billion | CN¥90.45 Million | CN¥688.60 Million | ▲ +225.6% |
| 2022 | 4.94x | CN¥1.28 Billion | CN¥259.41 Million | CN¥591.58 Million | ▲ +43.9% |
| 2021 | 3.44x | CN¥499.61 Million | CN¥145.42 Million | CN¥248.45 Million | ▼ -63.4% |
| 2020 | 9.40x | CN¥510.91 Million | CN¥54.36 Million | CN¥255.12 Million | ▲ +217.8% |
| 2019 | 2.96x | CN¥211.38 Million | CN¥71.47 Million | CN¥106.95 Million | — |